Cargando…
Glycomic-Based Biomarkers for Ovarian Cancer: Advances and Challenges
Ovarian cancer remains one of the most common causes of death among gynecological malignancies afflicting women worldwide. Among the gynecological cancers, cervical and endometrial cancers confer the greatest burden to the developing and the developed world, respectively; however, the overall surviv...
Autores principales: | Wanyama, Francis Mugeni, Blanchard, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065431/ https://www.ncbi.nlm.nih.gov/pubmed/33916250 http://dx.doi.org/10.3390/diagnostics11040643 |
Ejemplares similares
-
The Burden of Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses in Ovarian Cancer Patients in Nairobi, Kenya
por: Wanyama, Francis Mugeni, et al.
Publicado: (2022) -
The Serum Glycome to Discriminate between Early-Stage Epithelial Ovarian Cancer and Benign Ovarian Diseases
por: Biskup, Karina, et al.
Publicado: (2014) -
Capitalizing glycomic changes for improved biomarker-based cancer diagnostics
por: Silva, Maria Luísa S.
Publicado: (2023) -
Recent Advances in Cellular Glycomic Analyses
por: Furukawa, Jun-ichi, et al.
Publicado: (2013) -
Towards an integrated proteomic and glycomic approach to finding cancer biomarkers
por: Taylor, Allen D, et al.
Publicado: (2009)